Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
Public ClinicalTrials.gov record NCT01677572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
Study identification
- NCT ID
- NCT01677572
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Interventions
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2012
- Primary completion
- Jul 30, 2019
- Completion
- Jul 30, 2019
- Last update posted
- Aug 2, 2020
2012 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 14
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NNS Clinical Research, LLC | Tucson | Arizona | 85704 | — |
| Senior Clinical Trials, Inc. | Laguna Hills | California | 92653 | — |
| Torrance Clinical Research Institute, Inc. | Lomita | California | 90717 | — |
| Collaborative Neuroscience Network, LLC | Long Beach | California | 90806 | — |
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| Pacific Neuroscience Medical Group | Oxnard | California | 93030 | — |
| Pacific Research Network, Inc. | San Diego | California | 92103 | — |
| San Francisco Clinical Research Center | San Francisco | California | 94109 | — |
| Stanford University Medical Center | Stanford | California | 94304 | — |
| Alzheimer's Disease Research Unit, Yale University | New Haven | Connecticut | 06520 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20057 | — |
| Brain Matters Research, Inc. | Delray Beach | Florida | 33445 | — |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers | Florida | 33912 | — |
| MD Clinical Trials, Inc. | Hallandale | Florida | 33009 | — |
| Miami Jewish Health Systems | Miami | Florida | 33137 | — |
| Galiz Research, LLC | Miami Springs | Florida | 33166 | — |
| Compass Research, LLC | Orlando | Florida | 32806 | — |
| Infinity Clinical Research, Inc. | Sunrise | Florida | 33351 | — |
| Axiom Clinical Research of Florida | Tampa | Florida | 33609 | — |
| Stedman Clinical Trials, LLC | Tampa | Florida | 33613 | — |
| Neurostudies.net, LLC | Decatur | Georgia | 30033 | — |
| Alexian Brothers Neurosciences Institute | Elk Grove Village | Illinois | 60007 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| St. Louis Clinical Trials, LLC | St Louis | Missouri | 63118 | — |
| Memory Enhancement Center of America, Inc. | Eatontown | New Jersey | 07724 | — |
| CRI Lifetree | Marlton | New Jersey | 08053 | — |
| Advanced Memory Research Institute of NJ | Toms River | New Jersey | 08755 | — |
| Empire Neurology, PC | Latham | New York | 12110 | — |
| Insight Clinical Trials LLC | Beachwood | Ohio | 44122 | — |
| Summit Research Network (Oregon) Inc. | Portland | Oregon | 97210 | — |
| Brown Hospital | East Providence | Rhode Island | 02906 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01677572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2020 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01677572 live on ClinicalTrials.gov.